PharmaCyte Biotech Inc (PMCB)
2.15
+0.02
(+0.94%)
USD |
NASDAQ |
May 02, 15:21
PharmaCyte Biotech 1 Year Total Returns (Daily): -27.05% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -27.05% |
April 30, 2024 | -27.40% |
April 29, 2024 | -27.40% |
April 26, 2024 | -29.19% |
April 25, 2024 | -29.10% |
April 24, 2024 | -26.17% |
April 23, 2024 | -28.52% |
April 22, 2024 | -25.50% |
April 19, 2024 | -28.38% |
April 18, 2024 | -26.17% |
April 17, 2024 | -28.62% |
April 16, 2024 | -27.12% |
April 15, 2024 | -28.47% |
April 12, 2024 | -24.92% |
April 11, 2024 | -22.30% |
April 10, 2024 | -23.65% |
April 09, 2024 | -21.50% |
April 08, 2024 | -18.43% |
April 05, 2024 | -16.55% |
April 04, 2024 | -13.10% |
April 03, 2024 | -15.49% |
April 02, 2024 | -14.78% |
April 01, 2024 | -15.98% |
March 28, 2024 | -16.55% |
March 27, 2024 | -13.78% |
Date | Value |
---|---|
March 26, 2024 | -15.57% |
March 25, 2024 | -14.19% |
March 22, 2024 | -15.28% |
March 21, 2024 | -16.03% |
March 20, 2024 | -17.65% |
March 19, 2024 | -26.21% |
March 18, 2024 | -30.69% |
March 15, 2024 | -31.58% |
March 14, 2024 | -29.17% |
March 13, 2024 | -31.49% |
March 12, 2024 | -32.53% |
March 11, 2024 | -31.16% |
March 08, 2024 | -30.64% |
March 07, 2024 | -30.51% |
March 06, 2024 | -32.04% |
March 05, 2024 | -32.33% |
March 04, 2024 | -31.67% |
March 01, 2024 | -29.97% |
February 29, 2024 | -30.00% |
February 28, 2024 | -30.00% |
February 27, 2024 | -31.53% |
February 26, 2024 | -30.43% |
February 23, 2024 | -29.93% |
February 22, 2024 | -30.41% |
February 21, 2024 | -31.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.11%
Minimum
Feb 22 2022
56.54%
Maximum
Feb 24 2023
-36.02%
Average
-35.35%
Median
Apr 20 2020
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -35.16% |
AIM ImmunoTech Inc | -15.22% |
IGC Pharma Inc | 48.54% |
NovaBay Pharmaceuticals Inc | -91.85% |
Protalix BioTherapeutics Inc | -58.28% |